Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
Selecta Biosciences (SELB) Deep Dive Reveals Investors Should Focus on Catalysts - Cantor Fitzgerald
-
Cantor Fitzgerald Starts Selecta Biosciences (SELB) at Overweight
-
Selecta Biosciences (SELB) Announces $70 Million Private Placement of Common Stock, Warrants
-
Selecta Biosciences Announces $70 Million Private Placement
-
Selecta Biosciences (SELB) Names Brad Dahms as CFO
-
Selecta Biosciences Appoints Brad Dahms as Chief Financial Officer
-
Selecta Biosciences to Present at the Cantor Fitzgerald Global Healthcare Conference on October 02, 2018
-
Selecta Biosciences to Participate in Upcoming Investor Conferences
